Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Bladder Carcinoma

Bladder Carcinoma

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Bladder Carcinoma

3 trials tracked for Bladder Carcinoma: 1 in phase 3 or 4.

3Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 1 1 Other / NA 1
  1. Phase 3 Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy Completed
  2. Phase 1 A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) Completed
  3. N/A TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Disitamab vedotin and tislelizumab combination achieved remission of skin metastasis in a patient with bladder carcinoma
Orthopedics & Sports Medicine Sys. Review
Disitamab vedotin and tislelizumab combination achieved remission of skin metastasis in a patient with bladder carcinoma Drug Combo Clears Skin Metastasis in Bladder Cancer
This case report describes a 70-year-old man with muscle-invasive bladder carcinoma treated with a combination of disitamab vedotin and tisl…
A man's bladder cancer skin spread vanished after a two-drug combo, but it's just one case.
Frontiers Sep 4, 2026